Author

Keisuke Nakamura

Institutions: Oita University, MSD K.K. (Japan)

Observed institutions: Oita University, MSD K.K. (Japan)

ORCID: 0000-0003-0067-522X

Observed ORCID: 0000-0003-0067-522X

OpenAlex ID: A5080685488

A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19

2022 · Keisuke Nakamura, Katsukuni Fujimoto, et al. · Clinical and Translational Science · 19

Pharmacological and clinical profile of once weekly alendronate for the treatment of osteoporosis (Fosamac 35 mg/Bonalon 35 mg)

2007 · Shinji Uchida, Yoshiaki Azuma, et al. · Folia Pharmacologica Japonica

Works count: 2

Citation count: 19

H-index: 1

I10-index: 1